Firms
Forbion
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Gate Bioscience$65M · 2025-11-13
bluebird bio$60M · 2012-07-25
Gate Bio$65M · Unknown date
AiRNA$60M · Unknown date
AiRNA$155M · Unknown date
Atlas Venture
Pheon Therapeutics$120M · 2024-05-21Aiolos Bio$245M · 2023-10-25
Replimune$55M · Unknown date
Replimune Group$55M · Unknown date
Omega Funds
Protego Bio$130M · 2025-12-01
Protego$130M · 2025-12-01
Replimune$55M · Unknown date
Replimune Group$55M · Unknown date
Bain CapitalAiolos Bio$245M · 2023-10-25
Replimune$55M · Unknown date
Replimune Group$55M · Unknown date
Foresite Capital
Engrail Therapeutics$167M · 2024-03-19
Replimune$55M · Unknown date
Replimune Group$55M · Unknown date
Lightspeed
Protego Bio$130M · 2025-12-01
Protego$130M · 2025-12-01
Pheon Therapeutics$120M · 2024-05-21
Avego BioScience Capital
MapLight Therapeutics$150M · 2026-08-13
MapLight Therapeutics$200M · 2025-07-28
Cormorant Asset Management
Replimune$55M · Unknown date
Replimune Group$55M · Unknown date
Eli Lilly and Company
Gate Bioscience$65M · 2025-11-13
Gate Bio$65M · Unknown date
GV
Gate Bioscience$65M · 2025-11-13
Gate Bio$65M · Unknown date
Life Sciences at Goldman Sachs Alternatives
MapLight Therapeutics$150M · 2026-08-13
MapLight Therapeutics$200M · 2025-07-28
Longwood Fund
Progentos Therapeutics$65M · 2024-05-20
Engrail Therapeutics$167M · 2024-03-19
Versant Ventures
Gate Bioscience$65M · 2025-11-13
Gate Bio$65M · Unknown date
YK Bioventures
Protego Bio$130M · 2025-12-01
Protego$130M · 2025-12-01
5am Ventures
MapLight Therapeutics$200M · 2025-07-28
Alta Partners
Progentos Therapeutics$65M · 2024-05-20
Andreessen Horowitz (a16z) Bio + Health
Gate Bio$65M · Unknown date
Avid Ventures
Protego Bio$130M · 2025-12-01
Blue Owl Healthcare Opportunities
MapLight Therapeutics$200M · 2025-07-28
BVF Partners L.P.
Pheon Therapeutics$120M · 2024-05-21
Deep Track Capital
MapLight Therapeutics$150M · 2026-08-13
Deerfield
bluebird bio$60M · 2012-07-25
Digitalis Ventures
Protego$130M · 2025-12-01
Dolby Family Ventures
Progentos Therapeutics$65M · 2024-05-20
Eight Roads
Engrail Therapeutics$167M · 2024-03-19
F-Prime Capital
Engrail Therapeutics$167M · 2024-03-19
Mission BioCapital
Progentos Therapeutics$65M · 2024-05-20
MPM Capital
Protego Bio$130M · 2025-12-01
Nextech Invest Ltd.
AiRNA$155M · Unknown date
Norwest Venture Partners
Engrail Therapeutics$167M · 2024-03-19
Novo Holdings
MapLight Therapeutics$200M · 2025-07-28
Ono Venture Investment
AiRNA$60M · Unknown date
Pivotal bioVenture Partners
MapLight Therapeutics$200M · 2025-07-28
Pivotal Life Sciences
Engrail Therapeutics$167M · 2024-03-19
RA Capital Management
Aiolos Bio$245M · 2023-10-25
Red Tree Venture Capital
Engrail Therapeutics$167M · 2024-03-19
Research Corporation Technologies
Pheon Therapeutics$120M · 2024-05-21
RiverVest Venture Partners
Engrail Therapeutics$167M · 2024-03-19
Sanofi Ventures
bluebird bio$60M · 2012-07-25
Sofinnova PartnersAiolos Bio$245M · 2023-10-25
TCG
Pheon Therapeutics$120M · 2024-05-21
Third Rock Ventures
bluebird bio$60M · 2012-07-25
Venrock Healthcare Capital Partners
AiRNA$155M · Unknown date
Vineeta Agarwala
Gate Bioscience$65M · 2025-11-13
Y Combinator
Protego$130M · 2025-12-01
Ysios Capital
Engrail Therapeutics$167M · 2024-03-19